CVS Health is reportedly considering splitting into two publicly traded companies, separating its retail drugstores from its insurance and pharmacy benefit management units, including Aetna and Caremark. This move could reverse the 2018 Aetna acquisition and respond to political pressures against companies owning multiple drug chain steps. The split, possibly set for 2028, aims to unlock value hidden by the current combined structure but raises questions about debt division, costs, and operational impacts. CVS's upcoming earnings report may provide clarity on the plan and timeline.
CVS Health shares are trading at USD 92.35 with a 1.03% gain as of Nov 04, 2026 18:41 WIB on Pluang. The stock shows strong investor interest, with 91% of orders to buy and a dividend yield of 2.91%.
CVS Health announced plans to split into two separate public companies by mid-2028, undoing its $78 billion acquisition of insurer Aetna and breaking up its integrated healthcare business. The split will separate CVS's 9,000 retail pharmacies from it...
CVS Health announced plans to separate into two independent publicly traded companies by the first half of 2028. One company will focus on healthcare solutions, including Aetna and CVS Caremark, while the other will be a retail pharmacy company with ...
CVS Health reported a 5.4% increase in third-quarter revenues to $108.4 billion, driven by growth in its Health Services and Health Care Benefits segments. GAAP diluted EPS improved to $1.68 from a loss of $3.13 last year, while adjusted EPS rose to ...
CVS Health will divide into two separate companies, separating its retail pharmacy business from its insurance and pharmacy-benefit operations. One company will keep the CVS Health name and be led by CEO David Joyner. This move reverses CVS's previou...
CVS Health and McDonald's are set to report earnings soon, with both stocks labeled 'too cheap to ignore' by Jim Cramer despite underlying risks. CVS has shown strong earnings growth and raised its full-year guidance, but faces potential policy risks...
